Key Takeaways Sarepta Therapeutics shares were down roughly 17% late Friday morning. The tumble followed a report that a third…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2195902359-c6f5421a55f243058b334af344c18736.jpg?w=780&resize=780,470&ssl=1 "Sarepta Therapeutics Stock Tumbles on Report of Third Death in Clinical Trial")
Key Takeaways Sarepta Therapeutics shares were down roughly 17% late Friday morning. The tumble followed a report that a third…
Read More »